OKTA vs SGMT · P/E 84, rev $1.57B vs $403.2M cap
Okta Inc (OKTA) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
SGMT does not have a complete income-statement cache yet.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the OKTA and SGMT stock pages for the full models.
Not investment advice.